Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Background: Vertigo as acute symptom seem to be one of most common presentation in ED, can be treated in ED with multiple medication .

Objective: This study aimed to compare the therapeutic efficacy of metoclopramide, promethazine and prochloroperazine in patients presenting with signs and symptoms suggestive of acute peripheral vertigo to the ED .

Methods: A 3-arm multi-center, randomized, triple-blind, controlled study comparing three treatments for acute vertigo in three medical centers : AlNahdha hospital Oman , Sohar Hospital Oman and AFH hospital Oman. Oman From February 2022 to August 2024.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• □ Acute peripheral vertigo with nausea or vomiting (vas, visual analog scale \>5) during their emergency department episode of care for which the attending physician recommending antiemetic, onset with in 3 days .

⁃ Age( 18- 60).

Locations
Other Locations
Oman
Al Nahdha hospital, AFH and Sohar hospital
RECRUITING
Muscat
Contact Information
Primary
Asma Al Buraiki, MD
asma.b19@resident.omsb.org
+96896735469
Backup
Suad AlBulushi, MD master
suadbulushi@gmail.com
+96899266722
Time Frame
Start Date: 2022-02-01
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 90
Treatments
Active_comparator: Metoclopramid
IM Metoclopramid 10mg
Active_comparator: Promethazine
IM Promethazine 25mg
Active_comparator: prochloraperazine
IM prochloraperazine 12.5mg
Related Therapeutic Areas
Sponsors
Leads: Oman Medical Speciality Board

This content was sourced from clinicaltrials.gov